Erica L. Carpenter

Also affiliated with Philadelphia University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.122Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A prospective validation cohort study of baseline plasma cell-free DNA (cfDNA) as a prognostic biomarker in newly diagnosed glioblastoma (GBM).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2508

Top 71%

0.122DataRank

Top 71%1 citations

Seyed Ali Nabavizadeh, Jacob E. Till, Aseel Abdalla, Hareena Sanga, Jazmine J. Mays +11 more

Papers

Driven by 26 papers — median percentile 29. Top paper: “The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib”.

The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1467

N/A

0.873DataRank · unranked

24 citations

Arielle Yablonovitch, Jacob E. Till, Jennifer Yen, Lesli A. Kiedrowski, Ryan Hood +9 more

A prospective validation cohort study of baseline plasma cell-free DNA (cfDNA) as a prognostic biomarker in newly diagnosed glioblastoma (GBM).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2508

Top 71%

0.122DataRank

Top 71%1 citations

Seyed Ali Nabavizadeh, Jacob E. Till, Aseel Abdalla, Hareena Sanga, Jazmine J. Mays +11 more

Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa016

N/A

0DataRank · unranked

36 citations

Jeffrey B. Ware, Samantha Guiry, MacLean P. Nasrallah, Jazmine J. Mays, Jacob E. Till +11 more

THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement

Cancer Prevention Research(2020)10.1158/1940-6207.capr-20-0403

N/A

0DataRank · unranked

24 citations

Naomi Takenaka, William R. Bamlet, Ann L. Oberg, Stephanie S. Yee, Erica L. Carpenter +5 more

MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1826

N/A

0DataRank · unranked

100 citations

Robert J. Norgard, Timour Baslan, Komal S. Rathi, Amy Zhang, Asal Saeid +26 more

Systemic inflammation is a determinant of outcomes of CD40 agonist–based therapy in pancreatic cancer patients

JCI Insight(2021)10.1172/jci.insight.145389

N/A

0DataRank · unranked

34 citations

Veronica M. Herrera, Michael A. Giannone, Whitney L. Gladney, Erica L. Carpenter, Gregory L. Beatty +1 more

Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors

Scientific Reports(2021)10.1038/s41598-021-88239-y

N/A

0DataRank · unranked

31 citations

Michael J. LaRiviere, Eric A. Cohen, Thomas H. Buckingham, Stephanie S. Yee, Taylor A. Black +9 more

Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab011

N/A

0DataRank · unranked

27 citations

Jacob E. Till, Aseel Abdalla, Hareena K Sangha, Stephanie S. Yee, Jake M. Freedman +10 more

Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography

Cancers(2021)10.3390/cancers13235985

N/A

0DataRank · unranked

21 citations

Bardia Yousefi, Lacey Serletti, Maya Galperin-Aizenberg, Leonid Roshkovan, José Marcio Luna +6 more

EUS-based Pancreatic Cancer Surveillance in BRCA1/BRCA2/PALB2/ATM Carriers Without a Family History of Pancreatic Cancer

Cancer Prevention Research(2021)10.1158/1940-6207.capr-21-0161

N/A

0DataRank · unranked

10 citations

Jessica M. Long, Nuzhat A. Ahmad, Sara Attalla, Angela R. Bradbury, Erica L. Carpenter +16 more

THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma

Oncotarget(2021)10.18632/oncotarget.28099

N/A

0DataRank · unranked

5 citations

Jacob E. Till, Shirsa Udgata, Naomi Takenaka, Stephanie S. Yee, Michael J. LaRiviere +8 more

Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance

The Medicine Forum(2021)10.1101/2021.03.01.433120

N/A

0DataRank · unranked

2 citations

David M. Booth, J. Škoda, Madison C. Pedrotty, Jennifer Vogel, Kangning Liu +13 more

MYC controls metastatic heterogeneity in pancreatic cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.30.428641

N/A

0DataRank · unranked

1 citations

Robert J. Norgard, Timour Baslan, Komal S. Rathi, Amy X. Zhang, Pichai Raman +15 more

Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4122

N/A

0DataRank · unranked

1 citations

Aseel Abdalla, Neha Bhagwat, Taylor A. Black, Zhuoyang Wang, Stephanie S. Yee +15 more

Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100301

N/A

0DataRank · unranked

34 citations

Charu Aggarwal, Janeline Wong, Vivek Nimgaonkar, Wei‐Ting Hwang, Michelle Andronov +17 more

Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy

Scientific Reports(2022)10.1038/s41598-022-14160-7

N/A

0DataRank · unranked

24 citations

Hannah Horng, Leonid Roshkovan, Joanna K. Weeks, Michelle Hershman, Peter B. Noël +11 more

Modeling and optimization of parallelized immunomagnetic nanopore sorting for surface marker specific isolation of extracellular vesicles from complex media

Scientific Reports(2023)10.1038/s41598-023-39746-7

N/A

0DataRank · unranked

13 citations

Hanfei Shen, Griffin B. Spychalski, Erica L. Carpenter, David Issadore, Andrew A. Lin

Electroformed Inverse‐Opal Nanostructures for Surface‐Marker‐Specific Isolation of Extracellular Vesicles Directly from Complex Media

Advanced Materials Technologies(2023)10.1002/admt.202201622

N/A

0DataRank · unranked

7 citations

Zhimin Jiang, Stephanie S. Yee, Erica L. Carpenter, James H. Pikul, David Issadore +1 more

A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps626

N/A

0DataRank · unranked

3 citations

Andy J. Minn, Erica L. Carpenter, Edgar Ben-Josef, Thomas B. Karasic, Timothy J. Brown

Parallelized immunomagnetic nanopore sorting: modeling, scaling, and optimization of surface marker specific isolation of extracellular vesicles from complex media

Research Square(2023)10.21203/rs.3.rs-2913647/v1

N/A

0DataRank · unranked

2 citations

Hanfei Shen, Griffin B. Spychalski, Erica L. Carpenter, David Issadore, Andrew A. Lin

The identification of reversion mutations in patients with advanced pancreatic cancer and germline or somatic BRCA or PALB2 variants who were treated with maintenance rucaparib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.734

N/A

0DataRank · unranked

1 citations

Arielle Yablonovitch, Jennifer Yen, Lesli A. Kiedrowski, Erica L. Carpenter, Katherine L. Nathanson +3 more

Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-49915-5

N/A

0DataRank · unranked

13 citations

Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman +37 more

miRNA panel from HER2+ and CD24+ plasma extracellular vesicle subpopulations as biomarkers of early-stage breast cancer

Breast Cancer Research(2025)10.1186/s13058-025-02029-2

N/A

0DataRank · unranked

10 citations

Andrew A. Lin, Stephanie J. Yang, Hanfei Shen, J. Fernando del Rosario, Kyle Tien +11 more

Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis

The Journal of Experimental Medicine(2020)10.1084/jem.20190673

N/A

0DataRank · unranked

177 citations

Austin P. Huffman, Max M. Wattenberg, David M. Walter, Erica L. Carpenter, David M. Feldser +4 more

Development of a prognostic multiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first line immunotherapy

Scientific Reports(2025)10.1038/s41598-025-18101-y

N/A

0DataRank · unranked

2 citations

Hannah Horng, Leonid Roshkovan, Michelle Hershman, Eric A. Cohen, Charu Aggarwal +4 more

A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0632

N/A

0DataRank · unranked

19 citations

Max M. Wattenberg, Nevena Damjanov, Elizabeth Prechtel Dunphy, Mona Jacobs-Small, Maryanne J. Lubas +12 more

Erica L. Carpenter

Indexed papers

Top data-sharing exemplar

Papers